Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma
|
The Johns Hopkins University School of Medicine / David Loeb, MD, PhD |
Reach Grants |
2013 |
Maryland |
Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park / Christopher Jewell, PhD |
'A' Award Grants |
2013 |
Maryland |
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD, PhD |
Reach Grants |
2013 |
Michigan |
The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis |
Mayo Clinic / Shizhen Zhu, MD, PhD |
Young Investigator Grants |
2013 |
Minnesota |
Identification of Risk Factors for Pediatric Brain Tumors in a High Risk Population |
Washington University / Kimberly Johnson, PhD, MPH |
Epidemiology Grants |
2013 |
Missouri |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
|
Duke University Medical Center / Gerard Blobe, MD, PhD |
Reach Grants |
2013 |
North Carolina |
Nitrosative Stress And Symptom Severity During Childhood Leukemia Treatment |
Duke University Medical Center / Marilyn Hockenberry, RN, PhD |
Nurse Researcher Grants |
2013 |
North Carolina |
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma |
Duke University / Corinne Mary Linardic, MD, PhD |
Innovation Grants |
2013 |
North Carolina |